Annual SGA
$172.51 M
-$11.62 M-6.31%
December 31, 2023
Summary
- As of February 7, 2025, ADPT annual SGA is $172.51 million, with the most recent change of -$11.62 million (-6.31%) on December 31, 2023.
- During the last 3 years, ADPT annual SGA has risen by +$61.62 million (+55.57%).
- ADPT annual SGA is now -6.31% below its all-time high of $184.13 million, reached on December 31, 2022.
Performance
ADPT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$37.81 M
-$400.00 K-1.05%
September 30, 2024
Summary
- As of February 7, 2025, ADPT quarterly SGA is $37.81 million, with the most recent change of -$400.00 thousand (-1.05%) on September 30, 2024.
- Over the past year, ADPT quarterly SGA has dropped by -$4.82 million (-11.31%).
- ADPT quarterly SGA is now -24.74% below its all-time high of $50.24 million, reached on March 31, 2022.
Performance
ADPT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$4.84 B
-$195.24 M-4.20%
September 30, 2024
Summary
- As of February 7, 2025, ADPT TTM SGA is -$4.84 billion, with the most recent change of -$195.24 million (-4.20%) on September 30, 2024.
- Over the past year, ADPT TTM SGA has dropped by -$5.02 billion (-2908.12%).
- ADPT TTM SGA is now -1537.12% below its all-time high of -$295.91 million.
Performance
ADPT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ADPT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.3% | -11.3% | -2908.1% |
| 3 y3 years | +55.6% | -16.9% | -2638.1% |
| 5 y5 years | +284.3% | -16.9% | -2638.1% |
ADPT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.3% | +1.5% | -24.7% | at low | -91.5% | at low |
| 5 y | 5-year | -6.3% | +150.8% | -24.7% | +81.5% | -257.3% | at low |
| alltime | all time | -6.3% | +427.3% | -24.7% | +294.3% | -1537.1% | at low |
Adaptive Biotechnologies Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $37.81 M(-1.0%) | $160.57 M(-1.7%) |
| Jun 2024 | - | $38.21 M(-8.8%) | $163.32 M(-4.7%) |
| Mar 2024 | - | $41.92 M(-1.7%) | $171.29 M(-0.7%) |
| Dec 2023 | $172.51 M(-6.3%) | $42.63 M(+5.1%) | $172.51 M(-2.0%) |
| Sep 2023 | - | $40.57 M(-12.1%) | $176.03 M(-1.0%) |
| Jun 2023 | - | $46.17 M(+7.0%) | $177.72 M(+0.4%) |
| Mar 2023 | - | $43.14 M(-6.5%) | $177.03 M(-3.9%) |
| Dec 2022 | $184.13 M(+8.3%) | $46.14 M(+9.2%) | $184.13 M(-2.1%) |
| Sep 2022 | - | $42.27 M(-7.1%) | $188.03 M(-1.5%) |
| Jun 2022 | - | $45.48 M(-9.5%) | $190.86 M(+3.4%) |
| Mar 2022 | - | $50.24 M(+0.4%) | $184.66 M(+8.6%) |
| Dec 2021 | $169.97 M | $50.04 M(+11.0%) | $169.97 M(+11.9%) |
| Sep 2021 | - | $45.10 M(+14.8%) | $151.87 M(+13.9%) |
| Jun 2021 | - | $39.28 M(+10.5%) | $133.32 M(+10.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $35.54 M(+11.3%) | $120.61 M(+8.8%) |
| Dec 2020 | $110.89 M(+61.2%) | $31.94 M(+20.3%) | $110.89 M(+11.1%) |
| Sep 2020 | - | $26.55 M(-0.1%) | $99.78 M(+9.9%) |
| Jun 2020 | - | $26.57 M(+2.9%) | $90.80 M(+13.8%) |
| Mar 2020 | - | $25.83 M(+24.0%) | $79.79 M(+16.0%) |
| Dec 2019 | $68.78 M(+53.2%) | $20.83 M(+18.5%) | $68.78 M(+10.0%) |
| Sep 2019 | - | $17.58 M(+13.0%) | $62.52 M(+12.2%) |
| Jun 2019 | - | $15.56 M(+5.0%) | $55.72 M(+11.2%) |
| Mar 2019 | - | $14.82 M(+1.8%) | $50.13 M(+11.7%) |
| Dec 2018 | $44.90 M(+37.2%) | $14.57 M(+35.1%) | $44.90 M(+48.0%) |
| Sep 2018 | - | $10.78 M(+8.2%) | $30.33 M(+55.1%) |
| Jun 2018 | - | $9.96 M(+3.9%) | $19.55 M(+103.9%) |
| Mar 2018 | - | $9.59 M | $9.59 M |
| Dec 2017 | $32.71 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual SGA?
- What is the all time high annual SGA for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual SGA year-on-year change?
- What is Adaptive Biotechnologies quarterly SGA?
- What is the all time high quarterly SGA for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly SGA year-on-year change?
- What is Adaptive Biotechnologies TTM SGA?
- What is the all time high TTM SGA for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM SGA year-on-year change?
What is Adaptive Biotechnologies annual SGA?
The current annual SGA of ADPT is $172.51 M
What is the all time high annual SGA for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual SGA is $184.13 M
What is Adaptive Biotechnologies annual SGA year-on-year change?
Over the past year, ADPT annual SGA has changed by -$11.62 M (-6.31%)
What is Adaptive Biotechnologies quarterly SGA?
The current quarterly SGA of ADPT is $37.81 M
What is the all time high quarterly SGA for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly SGA is $50.24 M
What is Adaptive Biotechnologies quarterly SGA year-on-year change?
Over the past year, ADPT quarterly SGA has changed by -$4.82 M (-11.31%)
What is Adaptive Biotechnologies TTM SGA?
The current TTM SGA of ADPT is -$4.84 B
What is the all time high TTM SGA for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM SGA is -$295.91 M
What is Adaptive Biotechnologies TTM SGA year-on-year change?
Over the past year, ADPT TTM SGA has changed by -$5.02 B (-2908.12%)